Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 309.50
Bid: 311.00
Ask: 312.50
Change: -2.50 (-0.80%)
Spread: 1.50 (0.482%)
Open: 310.50
High: 312.00
Low: 309.50
Prev. Close: 312.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: BofA starts Pod Point at Buy; Barclays cuts DCC

Wed, 15th Dec 2021 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

SOCGEN CUTS BAE SYSTEMS PRICE TARGET TO 620 (660) PENCE - 'BUY'

----------

RBC CUTS ANGLO AMERICAN PRICE TARGET TO 3,150 (3,300) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS ANTOFAGASTA PRICE TARGET TO 1,700 (1,800) PENCE - 'BUY'

----------

RBC CUTS BP PRICE TARGET TO 410 (425) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES SHELL B PRICE TARGET TO 2,500 (2,350) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS UNILEVER PRICE TARGET TO 4,700 (4,800) PENCE - 'BUY'

----------

GOLDMAN RAISES TESCO PRICE TARGET TO 335 (320) PENCE - 'BUY'

----------

GOLDMAN RAISES J SAINSBURY PRICE TARGET TO 270 (265) PENCE - 'NEUTRAL'

----------

BARCLAYS CUTS VODAFONE PRICE TARGET TO 165 (170) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES PEARSON PRICE TARGET TO 625 (570) PENCE - 'HOLD'

----------

BARCLAYS CUTS DCC TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 5,550 (6,900) PENCE

----------

CREDIT SUISSE CUTS RENTOKIL INITIAL TARGET TO 600 (630) PENCE - 'OUTPERFORM'

----------

CITIGROUP CUTS RENTOKIL TO 'NEUTRAL' (BUY) - PRICE TARGET 650 (600) PENCE

----------

FTSE 250

----------

BERENBERG CUTS HARBOUR ENERGY TO 'HOLD' (BUY) - PRICE TARGET 350 (425) PENCE

----------

RBC CUTS HARBOUR ENERGY TO 'SECTOR PERFORM' (OUTPERFORM) - PRICE TARGET 480 (650) PENCE

----------

RBC RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,450 (14,30) PENCE - 'OUTPERFORM'

----------

BARCLAYS CUTS DOMINO'S PIZZA TO 'UNDERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 495 (500) PENCE

----------

UBS RAISES BALFOUR BEATTY PRICE TARGET TO 390 (370) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES BEAZLEY PRICE TARGET TO 415 (350) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

BOFA INITIATES POD POINT WITH 'BUY' - TARGET 450 PENCE

----------

RBC RAISES TULLOW OIL TO 'SECTOR PERFORM' (UNDERPERFORM) - PRICE TARGET 90 (70) PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more
30 Oct 2020 08:47

Oxford Biomedica partner delays Parkinson's disease treatment trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.

Read more
23 Oct 2020 15:15

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

Read more
6 Oct 2020 14:19

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Read more
6 Oct 2020 09:44

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Read more
6 Oct 2020 07:55

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

Read more
6 Oct 2020 07:43

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

Read more
6 Oct 2020 07:03

Oxford Biomedica new manufacturing suite approved

(Sharecast News) - Oxford Biomedica said it had received government approval for a fourth manufacturing suite within its Oxbox facility which will be used to develop a potential Covid-19 vaccine.

Read more
17 Sep 2020 10:43

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Read more
17 Sep 2020 08:35

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.